Mark Ganz, Former CEO at Cambia Health Solutions, Joins Innovaccer’s Strategic Advisory Board

Leading healthcare technology company Innovaccer Inc. announced that Mark Ganz, former CEO at Cambia Health Solutions, will join its Strategic Advisory Board. In his new role, Ganz will help Innovaccer drive innovation and advance the Innovaccer Health Cloud, the company’s platform for powering the future of health.

Ganz has more than 25 years of leadership experience at several payer and provider healthcare organizations. He is a board member at Portland General Electric, the University of Portland, the Cascade Pacific Council, Boy Scouts of America, Tournament Golf Foundation, and the Coalition to Transform Advanced Care (C-TAC). He is also a member of the Healthcare Executives Study Society, the Health Evolution Summit leadership circle, and the Aspen Group, an interdisciplinary group of senior leaders in healthcare policy and innovation.

For two decades, Ganz led Cambia in reimagining and reshaping healthcare to be more empathetic, transparent, and economically sustainable. Under Mark’s leadership, Cambia was one of only 125 global companies to receive designation as the World’s Most Ethical Corporations (3 year recipient). He was recognized by Modern Healthcare magazine as one of the “100 Most Influential in Health Care” in 2018 and 2019. He has also received the Health Care Transformer of the Year award, the Oregon Governors’ Gold Award, and a Sojourns Award in 2020.

Ganz has been a long time advocate for patient-centered and economically sustainable healthcare transformation for individuals and families in the U.S. His leadership experience and ability to scale cost-effective and profitable growth strategies will help Innovaccer eliminate data barriers in the U.S. healthcare system. His vision aligns with the company’s mission of connecting and curating the world’s data to make it accessible and useful.

“In addition to Innovaccer’s technical prowess, the company is deeply committed to making a substantial difference for individuals and families in healthcare,” said Ganz. “The company is passionate about creating a singular and integrated experience for people in their healthcare journeys. I’m excited to join them in their efforts.”

“Healthcare is undergoing rapid transformation, and companies need to harness the power of data to improve both clinical and financial outcomes,” said Abhinav Shashank, CEO at Innovaccer. “We are proud to be working with many of the leading companies across healthcare to help them unify their data silos, create a holistic view of their patients, and accelerate digital transformation. I’m thrilled to welcome Mark to the team and confident that his guidance will support our efforts to build the future of health on the Innovaccer Health Cloud.”

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.